CUV 1.85% $13.28 clinuvel pharmaceuticals limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797

    CLINUVEL recorded cash receipts of $11,442,000 and net operating cash flows of $4,087,000 for the
    March quarter of 2022. The results in cash receipts exceed the next highest comparative result by 75%


    Lies, damned lies and statistics.

    Compared with the average quarter for 2021 the results for Q122

    - cash receipts down 21%

    - Expenditures up

    - Cash flow down 45%






    -

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.28
Change
-0.250(1.85%)
Mkt cap ! $664.8M
Open High Low Value Volume
$13.55 $13.62 $13.25 $1.157M 86.45K

Buyers (Bids)

No. Vol. Price($)
1 227 $13.28
 

Sellers (Offers)

Price($) Vol. No.
$13.42 228 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.